
Nike Cuts Tech Jobs Amid Shift to Third-Party Vendors
May 20, 2025 02:49 am UTC| Business
Nike (NYSE:NKE) has begun laying off employees in its technology division, the company confirmed to Reuters. While the number of affected workers remains undisclosed, the sportswear giant stated that some responsibilities...

Foxconn and Nvidia to Build AI Data Center with 100MW Capacity in Taiwan
May 20, 2025 02:47 am UTC| Business Technology
Taiwans Foxconn (SS:601138), the worlds top contract electronics manufacturer, has revealed new details about its upcoming artificial intelligence center developed in partnership with U.S. tech giant Nvidia (NASDAQ:NVDA)....

CATL Shares Surge in $4.6B Hong Kong Listing Amid Strong Demand
May 20, 2025 02:45 am UTC| Business
Shares of Chinese battery giant CATL soared 12.5% above their offering price on Tuesday, debuting at HK$296 on the Hong Kong Stock Exchange after raising $4.6 billion. The offering, priced at HK$263 per share, marks the...

Waymo Expands California Robotaxi Approval Amid Tesla Competition
May 20, 2025 01:25 am UTC| Business
Alphabets autonomous driving division Waymo has secured regulatory approval to broaden its robotaxi service across more regions of California, including the San Francisco Peninsula and San Jose. The California Public...

Nippon Steel Ups U.S. Investment to $14B in Final Push for U.S. Steel Deal
May 20, 2025 01:23 am UTC| Business
Nippon Steel is pledging a massive $14 billion investment into U.S. Steels operations, including up to $4 billion for a new steel mill, in a last-ditch effort to gain Trump administration approval for its $14.9 billion...

GM Halts U.S. Vehicle Exports to China Amid Trade Tensions
May 20, 2025 01:21 am UTC| Business
General Motors (NYSE:GM) has announced it will stop exporting vehicles from the U.S. to China, citing shifting economic conditions and ongoing trade disputes between the two countries. The decision, communicated to...

Pfizer Signs $6B Cancer Drug Deal with China’s 3SBio
May 20, 2025 01:16 am UTC| Business Health
Pfizer has entered into a licensing agreement worth up to $6 billion with Chinese biopharmaceutical firm 3SBio Inc, aiming to advance a promising cancer treatment currently in clinical trials. The collaboration underscores...